Gastric phenotypic expression and histogenesis of metachronous gastric cancers endoscopically resected.
OBJECTIVE
Endoscopic Resection (ER) has been performed for early gastric cancers, and metachronous gastric cancers (MGCs) were occasionally observed. Most MGCs were classified histologically as the differentiated type. However, there have been no data on the gastric and intestinal phenotypic classification of MGCs. In our previous study, Hp-infection in MG may trigger intestinalization of gastric cancers. We therefore speculate the phenotype shift in MGC lesions under Hp-chronic-infection.


METHODS
We examined the 17 MGC lesions phenotypically and histologically by using several gastric and intestinal epithelial cell markers, MUC5AC, MUC6, MUC2 and villin.


RESULTS
Most lesions (16/17) exhibited the differentiated type. In 8 first cancers, the lesions were divided phenotypically into 2 G, 4 GI, 1 I, and 1 N types. In 9 second/third cancers, the lesions were divided phenotypically into 3 G, 1 GI, 4 I, and 1 N types. The first lesions (6/8) had more gastric phenotypic expression compared with the second/third ones (4/9) in the MGCs, although there was no significant difference between two groups (P = 0.28).


CONCLUSIONS
Our present data suggest the possibility that the cancer retaining G type is detected endoscopically earlier than that obtaining the intestinal phenotypic expression by the phenotypic shift, which may partially explain the MGC occurrence.
Mizoshita
Tsutomu
T
Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-cho, Mizuho-ku Nagoya 467-8601, Japan.
Kataoka
Hiromi
H
Tanida
Satoshi
S
Sasaki
Makoto
M
Ogasawara
Naotaka
N
Kubota
Eiji
E
Wada
Tsuneya
T
Yamada
Tomonori
T
Mori
Yoshinori
Y
Shimura
Takaya
T
Tsukamoto
Tetsuya
T
Tatematsu
Masae
M
Joh
Takashi
T
D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis; D016009:Chi-Square Distribution; D005773:Gastroscopy; D016481:Helicobacter Infections / Q000150:complications; D016480:Helicobacter pylori / Q000302:isolation & purification; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000473:pathology* / Q000601:surgery*; D010641:Phenotype; D013274:Stomach Neoplasms / Q000382:microbiology / Q000473:pathology* / Q000601:surgery*
D014408:Biomarkers, Tumor